Skip to main content

Table 1 Basic information on aCML patient and the age- and gender or age-matched controls analyzed in this study

From: Defective migration and dysmorphology of neutrophil granulocytes in atypical chronic myeloid leukemia treated with ruxolitinib

 

Controls (migration)

Controls (flow cytometry)

aCML

Individuals

6

5

1

Age [y] (median, range)

69 (66–74)

72 (68–74)

69

Sex (m:f)

6:0

2:3

male